Evidence map›Paper›PMID 30148842›Full record

ArticlePLoS biology2018

A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure.

Bryce A Mendelsohn, Neal K Bennett, Maxwell A Darch, Katharine Yu, Mai K Nguyen, Daniela Pucciarelli, Maxine Nelson, Max A Horlbeck, Luke A Gilbert, William Hyun and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. A pooled image-based CRISPR screen identifies EAF1 as abioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Genetic regulators of neuronal survival across metabolic environments.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Systems-level analyses dissociate genetic regulators of reactive oxygen species and energy production.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A new era in functional genomics screens.Nature reviews. Genetics · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Bryce A MendelsohnGladstone Institute of Neurological Disease, San Francisco, California, United States of America.
Neal K BennettGladstone Institute of Neurological Disease, San Francisco, California, United States of America.
Maxwell A DarchGladstone Institute of Neurological Disease, San Francisco, California, United States of America.
Katharine YuGladstone Institute of Neurological Disease, San Francisco, California, United States of America.
Mai K NguyenGladstone Institute of Neurological Disease, San Francisco, California, United States of America.
Daniela PucciarelliDepartment of Radiation Oncology, University of California, San Francisco, California, United States of America.
Maxine NelsonGraduate Program in Biomedical Sciences, University of California, San Francisco, California, United States of America.
Max A HorlbeckDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, California, United States of America.
Luke A GilbertDepartment of Urology, University of California, San Francisco, California, United States of America.
William HyunDepartment of Laboratory Medicine, University of California, San Francisco, California, United States of America.
Martin KampmannDepartment of Biochemistry and Biophysics and Institute for Neurodegenerative Diseases, University of California, San Francisco, California, United States of America.
Jean L NakamuraDepartment of Radiation Oncology, University of California, San Francisco, California, United States of America.
Ken NakamuraGladstone Institute of Neurological Disease, San Francisco, California, United States of America.ORCID 0000-0002-9192-182X
University of California, San Francisco · USGladstone Institutes · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Project 4: Secondary Cancers Among NF1 Cancer SurvivorsU54CA196519 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI Yunlong Liu · 2015 to 2026
$26.9M
PREDOCTORAL TRAINING IN BIOMEDICAL SCIENCEST32GM008568 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 1995 to 2019
$6.3M
Bay Area Cancer Target Discovery and Development NetworkU01CA168370 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCORMICK, FRANK PATRICK, MCMANUS, MICHAEL T · 2012 to 2016
$3.9M
Harnessing CRISPR for Targeted and Inducible Epigenomic ReprogrammingR01DA036858 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIM, WENDELL A, QI, LEI STANLEY · 2013 to 2017
$2.9M
Rewiring of the human protein homeostasis network in normal and disease contextsDP2GM119139 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMPMANN, MARTIN · 2015 to 2015
$2.3M
Determining how neural activity impairs bioenergetics in PD pathogenesisR01NS091902 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI NAKAMURA, KEN · 2015 to 2019
$2.1M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018928 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2003 to 2003
$2.1M
Novel Therapeutic Approaches to Alzheimer's DiseaseP30NS069496 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2009 to 2010
$1.7M
A functional genomics approach to determine the mechanism of cellular response to new anti-cancer R00CA204602 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GILBERT, LUKE · 2017 to 2019
$747k
NCI NIH HHS K99 CA204602NCI NIH HHS R00 CA204602NCI NIH HHS U01 CA168370NCI NIH HHS U54 CA196519NCRR NIH HHS C06 RR018928NCRR NIH HHS S10 RR028962NIAID NIH HHS P30 AI027763NICHD NIH HHS K12 HD000850NIDA NIH HHS R01 DA036858NIGMS NIH HHS DP2 GM119139NIGMS NIH HHS T32 GM007618NIGMS NIH HHS T32 GM008568NINDS NIH HHS P30 NS069496NINDS NIH HHS R01 NS091902
6 · The paper itself

Abstract

Insufficient or dysregulated energy metabolism may underlie diverse inherited and degenerative diseases, cancer, and even aging itself. ATP is the central energy carrier in cells, but critical pathways for regulating ATP levels are not systematically understood. We combined a pooled clustered regularly interspaced short palindromic repeats interference (CRISPRi) library enriched for mitochondrial genes, a fluorescent biosensor, and fluorescence-activated cell sorting (FACS) in a high-throughput genetic screen to assay ATP concentrations in live human cells. We identified genes not known to be involved in energy metabolism. Most mitochondrial ribosomal proteins are essential in maintaining ATP levels under respiratory conditions, and impaired respiration predicts poor growth. We also identified genes for which coenzyme Q10 (CoQ10) supplementation rescued ATP deficits caused by knockdown. These included CoQ10 biosynthetic genes associated with human disease and a subset of genes not linked to CoQ10 biosynthesis, indicating that increasing CoQ10 can preserve ATP in specific genetic contexts. This screening paradigm reveals mechanisms of metabolic control and genetic defects responsive to energy-based therapies.

Indexed as

Adenosine TriphosphateClustered Regularly Interspaced Short Palindromic RepeatsEnergy MetabolismHigh-Throughput Screening AssaysHumansMitochondriaMitochondrial ProteinsSingle-Cell AnalysisUbiquinoneAdenosine Triphosphatecoenzyme Q10Mitochondrial ProteinsUbiquinone

Identifiers

PMID30148842
PMCPMC6110572
OpenAlexW2889112481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.